Letter to the Editor
Dysphonia Induced by Selective Serotonin Reuptake Inhibitors
Abstract
Dysphonias are speech disorders resulting from voice disturbances, and iatrogenic dysphonias should be considered in the differential diagnosis of any patient presenting with a voice disorder. The most frequently cited medications that may cause dysphonia include corticosteroids, androgens, progesterone, diuretics, and tricyclic antidepressants.1 We report two cases of dysphonia related to selective serotonin reuptake inhibitor (SSRI) intake, one involving paroxetine and the other, fluoxetine. Both were prescribed at the recommended daily dose. The main characteristic of these two cases is the complete cessation of vocal symptoms immediately after SSRI withdrawal.This content is limited to qualifying members.
Existing members, please login first
If you have an existing account please login now to access this article or view purchase options.
Purchase only this article ($25)
Create a free account, then purchase this article to download or access it online for 24 hours.
Purchase an SMJ online subscription ($75)
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
Purchase a membership plan (fees vary)
Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.
References
1. Spiegel JR, Hawkshaw M, Thayer Sataloff R. Dysphonia related to medical therapy. Otolaryngol Clin North Am 2000;33:771–784.
2. Nielsen AS, Mors O. Choreiform dyskinesia with acute onset and protracted course following fluoxetine treatment. J Clin Psychiatry 1999;60:868–869.
3. Guthrie S, Grunhaus L. Fluoxetine-induced stuttering. J Clin Psychiatry 1990;51:85.
4. Fox GC, Ebeid S, Vincenti G. Paroxetine-induced chorea. Br J Psychiatry 1997;170:193–194.
5. Murray V. Laryngeal dystonia. Br J Psychiatry 1995;167:698–699.
